nodes	percent_of_prediction	percent_of_DWPC	metapath
Methantheline—CHRM1—Monoamine GPCRs—DRD5—bipolar disorder	0.0195	0.0198	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.0194	0.0197	CbGpPWpGaD
Methantheline—HRH2—Amine ligand-binding receptors—DRD1—bipolar disorder	0.0189	0.0192	CbGpPWpGaD
Methantheline—HRH2—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.0189	0.0192	CbGpPWpGaD
Methantheline—HRH2—Amine ligand-binding receptors—DRD3—bipolar disorder	0.0183	0.0186	CbGpPWpGaD
Methantheline—HRH2—Amine ligand-binding receptors—DRD4—bipolar disorder	0.0178	0.018	CbGpPWpGaD
Methantheline—HRH2—Amine ligand-binding receptors—DRD2—bipolar disorder	0.0166	0.0168	CbGpPWpGaD
Methantheline—CHRM1—Amine ligand-binding receptors—DRD5—bipolar disorder	0.0164	0.0166	CbGpPWpGaD
Methantheline—Protriptyline—SLC6A4—bipolar disorder	0.0139	1	CrCbGaD
Methantheline—HRH2—G alpha (s) signalling events—DRD5—bipolar disorder	0.0139	0.0141	CbGpPWpGaD
Methantheline—HRH2—Monoamine GPCRs—HTR2A—bipolar disorder	0.0138	0.014	CbGpPWpGaD
Methantheline—HRH2—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.0116	0.0118	CbGpPWpGaD
Methantheline—CHRM1—Monoamine GPCRs—HTR1A—bipolar disorder	0.0114	0.0115	CbGpPWpGaD
Methantheline—CHRM1—Monoamine GPCRs—HTR2C—bipolar disorder	0.011	0.0111	CbGpPWpGaD
Methantheline—CHRM1—Monoamine GPCRs—DRD1—bipolar disorder	0.011	0.0111	CbGpPWpGaD
Methantheline—CHRM1—Monoamine GPCRs—DRD3—bipolar disorder	0.0106	0.0108	CbGpPWpGaD
Methantheline—CHRM1—Monoamine GPCRs—DRD4—bipolar disorder	0.0103	0.0105	CbGpPWpGaD
Methantheline—HRH2—G alpha (s) signalling events—ADM—bipolar disorder	0.01	0.0102	CbGpPWpGaD
Methantheline—HRH2—G alpha (s) signalling events—PDE4B—bipolar disorder	0.00977	0.00991	CbGpPWpGaD
Methantheline—HRH2—G alpha (s) signalling events—TSHB—bipolar disorder	0.00977	0.00991	CbGpPWpGaD
Methantheline—CHRM1—Monoamine GPCRs—DRD2—bipolar disorder	0.00962	0.00976	CbGpPWpGaD
Methantheline—CHRM1—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.00956	0.0097	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.00945	0.00959	CbGpPWpGaD
Methantheline—CHRM1—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.00923	0.00936	CbGpPWpGaD
Methantheline—CHRM1—Amine ligand-binding receptors—DRD1—bipolar disorder	0.00923	0.00936	CbGpPWpGaD
Methantheline—CHRM1—Amine ligand-binding receptors—DRD3—bipolar disorder	0.00894	0.00907	CbGpPWpGaD
Methantheline—CHRM1—Amine ligand-binding receptors—DRD4—bipolar disorder	0.00868	0.0088	CbGpPWpGaD
Methantheline—CHRM1—Amine ligand-binding receptors—DRD2—bipolar disorder	0.00809	0.0082	CbGpPWpGaD
Methantheline—HRH2—G alpha (s) signalling events—DRD1—bipolar disorder	0.00781	0.00792	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00771	0.00782	CbGpPWpGaD
Methantheline—HRH2—G alpha (s) signalling events—ADCY2—bipolar disorder	0.00691	0.00701	CbGpPWpGaD
Methantheline—CHRM1—Monoamine GPCRs—HTR2A—bipolar disorder	0.00674	0.00683	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00661	0.0067	CbGpPWpGaD
Methantheline—CHRM1—Calcium Regulation in the Cardiac Cell—RGS4—bipolar disorder	0.00573	0.00581	CbGpPWpGaD
Methantheline—CHRM1—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.00566	0.00574	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—DGKH—bipolar disorder	0.00532	0.0054	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—DRD5—bipolar disorder	0.00503	0.0051	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—NR1D1—bipolar disorder	0.0049	0.00497	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—bipolar disorder	0.00476	0.00483	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00466	0.00472	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00466	0.00472	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.0045	0.00456	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00435	0.00441	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00435	0.00441	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00421	0.00427	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00409	0.00414	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00385	0.00391	CbGpPWpGaD
Methantheline—HRH2—G alpha (s) signalling events—POMC—bipolar disorder	0.00383	0.00388	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00381	0.00386	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.0038	0.00385	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00376	0.00382	CbGpPWpGaD
Methantheline—CHRM1—Calcium Regulation in the Cardiac Cell—CACNA1C—bipolar disorder	0.00376	0.00382	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00372	0.00378	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00372	0.00378	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—TRPC3—bipolar disorder	0.00369	0.00374	CbGpPWpGaD
Methantheline—CHRM1—Regulation of Actin Cytoskeleton—PIK3C2A—bipolar disorder	0.00367	0.00372	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—ADM—bipolar disorder	0.00364	0.00369	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00361	0.00366	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—TACR1—bipolar disorder	0.00355	0.0036	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—TSHB—bipolar disorder	0.00355	0.0036	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.0035	0.00355	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—TACR1—bipolar disorder	0.00343	0.00348	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—CLOCK—bipolar disorder	0.00332	0.00337	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.0033	0.00335	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00326	0.00331	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—TPH2—bipolar disorder	0.00324	0.00328	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00322	0.00327	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—DGKH—bipolar disorder	0.00311	0.00315	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.00307	0.00311	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—HTR1A—bipolar disorder	0.00294	0.00298	CbGpPWpGaD
Methantheline—CHRM1—Calcium Regulation in the Cardiac Cell—ADCY2—bipolar disorder	0.00291	0.00295	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—TAC1—bipolar disorder	0.00289	0.00293	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—DRD5—bipolar disorder	0.00284	0.00288	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—DRD1—bipolar disorder	0.00283	0.00287	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—HTR2C—bipolar disorder	0.00283	0.00287	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—DGKH—bipolar disorder	0.00282	0.00286	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—TAC1—bipolar disorder	0.0028	0.00284	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—RGS4—bipolar disorder	0.00279	0.00283	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—DRD3—bipolar disorder	0.00275	0.00278	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—HTR2C—bipolar disorder	0.00274	0.00278	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00267	0.0027	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—DRD4—bipolar disorder	0.00267	0.0027	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—DRD1—bipolar disorder	0.00259	0.00262	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—SLC6A4—bipolar disorder	0.00259	0.00262	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—DRD5—bipolar disorder	0.00258	0.00262	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—RGS4—bipolar disorder	0.00253	0.00257	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—DRD3—bipolar disorder	0.00251	0.00254	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.0025	0.00254	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—DRD2—bipolar disorder	0.00248	0.00252	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—DRD5—bipolar disorder	0.00246	0.00249	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.00245	0.00249	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—DRD4—bipolar disorder	0.00243	0.00247	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00228	0.00232	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00227	0.0023	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00227	0.0023	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—DRD2—bipolar disorder	0.00227	0.0023	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00219	0.00223	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—TRPC3—bipolar disorder	0.00216	0.00219	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00212	0.00215	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00212	0.00215	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—ADM—bipolar disorder	0.00206	0.00209	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00205	0.00208	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—NTRK1—bipolar disorder	0.00205	0.00208	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—TSHB—bipolar disorder	0.002	0.00203	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—PDE4B—bipolar disorder	0.002	0.00203	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—TACR1—bipolar disorder	0.002	0.00203	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00199	0.00202	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—TRPC3—bipolar disorder	0.00196	0.00199	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00188	0.00191	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—ADM—bipolar disorder	0.00187	0.00189	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00186	0.00188	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00185	0.00188	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00182	0.00185	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—TSHB—bipolar disorder	0.00182	0.00185	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—TACR1—bipolar disorder	0.00182	0.00185	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PDE4B—bipolar disorder	0.00182	0.00185	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00182	0.00184	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00182	0.00184	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AKR1C4—bipolar disorder	0.00181	0.00184	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—ADM—bipolar disorder	0.00178	0.0018	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00176	0.00178	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—HTR2A—bipolar disorder	0.00174	0.00176	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—TSHB—bipolar disorder	0.00173	0.00175	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—TACR1—bipolar disorder	0.00173	0.00175	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00171	0.00173	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00168	0.00171	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—DGKH—bipolar disorder	0.00167	0.00169	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—HTR1A—bipolar disorder	0.00166	0.00168	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—TAC1—bipolar disorder	0.00163	0.00166	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—HTR2C—bipolar disorder	0.0016	0.00162	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—DRD1—bipolar disorder	0.0016	0.00162	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00159	0.00161	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—DRD3—bipolar disorder	0.00155	0.00157	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—DRD5—bipolar disorder	0.00153	0.00155	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—DGKH—bipolar disorder	0.00152	0.00154	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—HTR1A—bipolar disorder	0.00151	0.00153	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—DRD4—bipolar disorder	0.00151	0.00153	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.0015	0.00153	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—RGS4—bipolar disorder	0.0015	0.00152	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—TAC1—bipolar disorder	0.00148	0.0015	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—HTR2C—bipolar disorder	0.00145	0.00148	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—DRD1—bipolar disorder	0.00145	0.00148	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—HTR1A—bipolar disorder	0.00143	0.00145	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—ADCY2—bipolar disorder	0.00142	0.00144	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—TAC1—bipolar disorder	0.00141	0.00143	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—DRD3—bipolar disorder	0.00141	0.00143	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—DRD2—bipolar disorder	0.0014	0.00142	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—POMC—bipolar disorder	0.00139	0.00141	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—DRD5—bipolar disorder	0.00139	0.00141	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—DRD1—bipolar disorder	0.00138	0.0014	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—HTR2C—bipolar disorder	0.00138	0.0014	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—DGKH—bipolar disorder	0.00138	0.0014	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—DRD4—bipolar disorder	0.00137	0.00139	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—RGS4—bipolar disorder	0.00136	0.00138	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—DRD3—bipolar disorder	0.00134	0.00136	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.0013	0.00132	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—DRD4—bipolar disorder	0.0013	0.00132	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—ADCY2—bipolar disorder	0.00129	0.00131	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—GSK3B—bipolar disorder	0.00128	0.0013	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—DRD2—bipolar disorder	0.00127	0.00129	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—DRD5—bipolar disorder	0.00126	0.00128	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—RGS4—bipolar disorder	0.00124	0.00125	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—DRD2—bipolar disorder	0.00121	0.00123	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TRPC3—bipolar disorder	0.00116	0.00117	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00111	0.00113	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ADM—bipolar disorder	0.0011	0.00112	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PDE4B—bipolar disorder	0.00108	0.00109	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TSHB—bipolar disorder	0.00108	0.00109	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TACR1—bipolar disorder	0.00108	0.00109	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—TRPC3—bipolar disorder	0.00105	0.00107	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—ADM—bipolar disorder	0.001	0.00102	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—HTR2A—bipolar disorder	0.000983	0.000997	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—TSHB—bipolar disorder	0.000978	0.000991	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PDE4B—bipolar disorder	0.000978	0.000991	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—TACR1—bipolar disorder	0.000978	0.000991	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—TRPC3—bipolar disorder	0.000955	0.000968	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—ADM—bipolar disorder	0.000911	0.000924	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—HTR2A—bipolar disorder	0.000892	0.000905	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—HTR1A—bipolar disorder	0.00089	0.000902	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00089	0.000902	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—TSHB—bipolar disorder	0.000888	0.0009	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PDE4B—bipolar disorder	0.000888	0.0009	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—TACR1—bipolar disorder	0.000888	0.0009	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AKR1C4—bipolar disorder	0.000884	0.000897	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TAC1—bipolar disorder	0.000876	0.000889	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—DRD1—bipolar disorder	0.000859	0.000872	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—HTR2C—bipolar disorder	0.000859	0.000872	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—HTR2A—bipolar disorder	0.000848	0.00086	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NTRK2—bipolar disorder	0.000836	0.000848	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—DRD3—bipolar disorder	0.000832	0.000844	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—GSK3A—bipolar disorder	0.000829	0.00084	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—DGKH—bipolar disorder	0.000814	0.000825	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—HTR1A—bipolar disorder	0.000809	0.000821	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—DRD4—bipolar disorder	0.000808	0.000819	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—TAC1—bipolar disorder	0.000797	0.000808	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—POMC—bipolar disorder	0.000785	0.000796	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—DRD1—bipolar disorder	0.000782	0.000793	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—HTR2C—bipolar disorder	0.000782	0.000793	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ADCY2—bipolar disorder	0.000761	0.000771	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TCF7L2—bipolar disorder	0.000758	0.000769	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—DRD3—bipolar disorder	0.000757	0.000768	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—DRD2—bipolar disorder	0.000753	0.000763	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—DRD5—bipolar disorder	0.000744	0.000755	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—HTR1A—bipolar disorder	0.000735	0.000745	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—DRD4—bipolar disorder	0.000735	0.000745	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—RGS4—bipolar disorder	0.00073	0.00074	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—TAC1—bipolar disorder	0.000724	0.000734	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—POMC—bipolar disorder	0.000713	0.000723	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—HTR2C—bipolar disorder	0.00071	0.00072	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—DRD1—bipolar disorder	0.00071	0.00072	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—ADCY2—bipolar disorder	0.000692	0.000701	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—DRD3—bipolar disorder	0.000687	0.000697	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—DRD2—bipolar disorder	0.000685	0.000694	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NTRK1—bipolar disorder	0.000682	0.000691	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—POMC—bipolar disorder	0.000678	0.000687	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—DRD4—bipolar disorder	0.000667	0.000677	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—S100B—bipolar disorder	0.000662	0.000672	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—ADCY2—bipolar disorder	0.000628	0.000637	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—DRD2—bipolar disorder	0.000622	0.00063	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NRG1—bipolar disorder	0.000585	0.000593	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TRPC3—bipolar disorder	0.000564	0.000572	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ADM—bipolar disorder	0.000538	0.000546	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—HTR2A—bipolar disorder	0.000527	0.000535	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TSHB—bipolar disorder	0.000524	0.000532	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TACR1—bipolar disorder	0.000524	0.000532	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PDE4B—bipolar disorder	0.000524	0.000532	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000479	0.000486	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—HTR2A—bipolar disorder	0.000435	0.000442	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HTR1A—bipolar disorder	0.000434	0.00044	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TAC1—bipolar disorder	0.000428	0.000434	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—GSK3B—bipolar disorder	0.000424	0.00043	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—POMC—bipolar disorder	0.000421	0.000427	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—DRD1—bipolar disorder	0.000419	0.000425	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HTR2C—bipolar disorder	0.000419	0.000425	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—INS—bipolar disorder	0.000419	0.000425	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NTRK2—bipolar disorder	0.000408	0.000414	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—DRD3—bipolar disorder	0.000406	0.000412	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	0.000404	0.00041	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—DRD4—bipolar disorder	0.000394	0.0004	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	0.000383	0.000388	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	0.000371	0.000376	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	0.00037	0.000375	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—DRD2—bipolar disorder	0.000367	0.000372	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—POMC—bipolar disorder	0.000348	0.000353	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	0.000332	0.000337	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—S100B—bipolar disorder	0.000323	0.000328	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NRG1—bipolar disorder	0.000285	0.000289	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	0.000257	0.000261	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	0.000207	0.00021	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—POMC—bipolar disorder	0.000205	0.000208	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—INS—bipolar disorder	0.000204	0.000207	CbGpPWpGaD
